ARTICLE | Company News
Antigenics, Virbac S.A. deal
March 22, 2004 8:00 AM UTC
AGEN sold to Virbac the manufacturing rights to its feline leukemia virus (FeLV) vaccine for $14.3 million in cash. Virbac already holds exclusive worldwide marketing rights to the vaccine, which AGEN...